Vaccine research for gonococcal infections: where are we?
about
Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challengeAntimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative actionTwenty-five-year changing pattern of gonococcal antimicrobial susceptibility in Shanghai: surveillance and its impact on treatment guidelines.A doctor's dilemma: choices amidst changeThe potential impact of vaccination on the prevalence of gonorrhea.Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century.Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae.Both MisR (CpxR) and MisS (CpxA) Are Required for Neisseria gonorrhoeae Infection in a Murine Model of Lower Genital Tract Infection.Infection: Proof of principle for effectiveness of a gonorrhoea vaccine.Structure-based design of ferritin nanoparticle immunogens displaying antigenic loops of Neisseria gonorrhoeae.Deciphering function of new gonococcal vaccine antigens using phenotypic microarrays.Pathogenesis of Neisseria gonorrhoeae in the female reproductive tract: neutrophilic host response, sustained infection, and clinical sequelae.Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.Transcriptome Analysis of Neisseria gonorrhoeae during Natural Infection Reveals Differential Expression of Antibiotic Resistance Determinants between Men and Women.Structure of the Recombinant Adhesin Complex Protein (rNg-ACP) and Generation of Murine Antibodies with Bactericidal Activity against GonococciStructure-Function Relationships of the Neisserial EptA Enzyme Responsible for Phosphoethanolamine Decoration of Lipid A: Rationale for Drug Targeting
P2860
Q26796265-2A0C91EF-1926-4CA3-8660-41EF592B7A87Q32383726-FD96FF29-69DD-4713-8A96-EC145CE4DB6FQ35102409-8D742E3C-066C-4324-B996-48D2F4B45BEFQ36106025-97616E69-DB6A-4EFF-9FD6-6D2A7E5AB413Q36551134-C75221D1-B3B4-4F19-AFB3-E202BCE5D47BQ37036002-FDEBEEE3-732D-4F7B-A120-D85EC37081F0Q37120976-D1D7A1AB-03D0-464E-9418-FDF1C23F9D50Q38675370-2F61BB80-6036-49AE-BAFB-82789C517B25Q38708059-CE43DA99-D629-424C-BF77-0E0556C65866Q40072827-E365439D-606F-4514-8316-18A690536149Q40104608-B6B7B810-6B70-4020-9CAB-70F6F538925CQ40166275-B58100DB-8087-40CE-94F8-77DA317CD961Q45069667-6E7410BA-9BD6-4143-BEFB-4E79939E95D4Q55364687-315D8AB7-6EA3-4456-847F-352CD9A1CE5BQ55489627-83E9F62D-A35A-472A-BA36-268341839D16Q57285397-21AEB44A-5CB3-467F-8731-285EC82D69CAQ58728451-897C0C15-730D-4DB6-B764-C1FD9D0496D8
P2860
Vaccine research for gonococcal infections: where are we?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vaccine research for gonococcal infections: where are we?
@en
type
label
Vaccine research for gonococcal infections: where are we?
@en
prefLabel
Vaccine research for gonococcal infections: where are we?
@en
P2860
P1476
Vaccine research for gonococcal infections: where are we?
@en
P2093
Ann E Jerse
Carolyn D Deal
P2860
P304
P356
10.1136/SEXTRANS-2013-051225
P478
89 Suppl 4
P577
2013-12-01T00:00:00Z